Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
SVP & Chief Commercial Officer
-
Stock Symbol
-
EYPT on Nasdaq
David Scott Jones - trading volume in the past year for EyePoint Pharmaceuticals, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
44.9K |
$1.29M |
$28.80 |
Feb 9, 2024 |
Direct |
|
|
| Restricted Stock Units |
5K |
$144K |
$28.80 |
Feb 9, 2024 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
4.38K |
|
|
Feb 2, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.